HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Non-nucleoside RT Inhibitors*
暂无分享,去创建一个
S. Sarafianos | K. Palczewski | S. Oka | E. Kodama | B. Marchand | E. Michailidis | A. Hachiya | Kamalendra Singh | J. Tanuma | K. Kirby | Y. T. Ong | Xiongying Tu | Zhe Li | Matthew M. Schuckmann | Daniel T Griffin